Skip to main content
. 2022 Jan 26;19(4):254–267. doi: 10.1038/s41571-022-00600-w

Fig. 1. Proposed mechanisms of immune-related adverse events.

Fig. 1

Schema depicting the interaction of T cells with malignant or non-malignant cells, and the molecular mechanisms of immune-checkpoint blockade. Tumour-specific (left) and non-tumour-specific (right) aspects associated with the development of irAEs are also included. ADCC, antibody-dependent cellular cytotoxicity; NK cell, natural killer cell; TCR, T cell receptor.